U researchers have earned a patent for a new kind of injectable antidote for cyanide poisoning.
The U.S. Patent and Trademark Office issued the new patent to the U of M Regents on Sept. 12, a little over a year after the team of local scientists made their initial application—a very short timeline in the context of typical patent office deliberations.
The full story was published in September, 2017, in Twin Cities Business.